![Yong Qing Cheng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yong Qing Cheng
Amministratore Delegato presso Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Posizioni attive di Yong Qing Cheng
Società | Posizione | Inizio | Fine |
---|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
![]() Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Amministratore Delegato | 24/09/1992 | - |
Presidente | 24/09/1992 | - | |
Fondatore | 24/09/1992 | - |
Storia della carriera di Yong Qing Cheng
Formazione di Yong Qing Cheng
China Europe International Business School | Masters Business Admin |
Peking Union Medical College | Graduate Degree |
West China School of Pharmacy | Undergraduate Degree |
Statistiche
Distribuzione geografica
Cina | 5 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Settori
Consumer Services | 4 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
![]() | Health Technology |
- Borsa valori
- Insiders
- Yong Qing Cheng
- Esperienza